1. Home
  2. FTF vs ACIU Comparison

FTF vs ACIU Comparison

Compare FTF & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

HOLD

Current Price

$5.88

Market Cap

240.8M

Sector

Finance

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.84

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTF
ACIU
Founded
N/A
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.8M
213.3M
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
FTF
ACIU
Price
$5.88
$2.84
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
167.5K
309.9K
Earning Date
01-01-0001
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$635.38
Revenue Next Year
N/A
$232.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.57
$1.43
52 Week High
$6.54
$4.00

Technical Indicators

Market Signals
Indicator
FTF
ACIU
Relative Strength Index (RSI) 27.49 45.19
Support Level $5.86 $2.57
Resistance Level $6.26 $2.99
Average True Range (ATR) 0.06 0.24
MACD -0.01 0.02
Stochastic Oscillator 4.35 25.64

Price Performance

Historical Comparison
FTF
ACIU

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective, is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: